Bristol-Myers Squibb Co.

Measures the adequacy of a Bristol-Myers Squibb Co.'s cash resources to meet its near-term cash obligations.

• Ratios (Summary)
• Current Ratio
• Quick Ratio
• Cash Ratio

Assets components shown as percentage of total assets.

Measures how efficiently Bristol-Myers Squibb Co. generates revenues from its investments in fixed or total assets.

• Ratios (Summary)
• Net Fixed Asset Turnover
• Total Asset Turnover
• Equity Turnover

To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.

• Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
• EV to EBITDA Ratio, Current
• EV to EBITDA Ratio, Historical

The assets reports major classes and amounts of resources owned or controlled by Bristol-Myers Squibb Co..

Comprehensive income is the change in equity (net assets) of Bristol-Myers Squibb Co. during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.